$2.67T
Total marketcap
$46.73B
Total volume
BTC 49.89%     ETH 17.08%
Dominance

Dynavax DVAX Stock

11.53 USD {{ price }} 0.260867% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
1.51B USD
LOW - HIGH [24H]
11.38 - 11.65 USD
VOLUME [24H]
1.95M USD
{{ volume }}
P/E Ratio
164.71
Earnings per share
0.07 USD

Dynavax Price Chart

Dynavax DVAX Financial and Trading Overview

Dynavax stock price 11.53 USD
Previous Close 12.62 USD
Open 12.63 USD
Bid 0 USD x 3200
Ask 0 USD x 1400
Day's Range 12.58 - 13.03 USD
52 Week Range 9.42 - 17.48 USD
Volume 2.18M USD
Avg. Volume 1.29M USD
Market Cap 1.67B USD
Beta (5Y Monthly) 1.484507
PE Ratio (TTM) 8.254777
EPS (TTM) 0.07 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 22.8 USD

DVAX Valuation Measures

Enterprise Value 1.23B USD
Trailing P/E 8.254777
Forward P/E -51.84
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.539928
Price/Book (mrq) 2.9535096
Enterprise Value/Revenue 1.872
Enterprise Value/EBITDA 4.592

Trading Information

Dynavax Stock Price History

Beta (5Y Monthly) 1.484507
52-Week Change 25.70%
S&P500 52-Week Change 20.43%
52 Week High 17.48 USD
52 Week Low 9.42 USD
50-Day Moving Average 11.14 USD
200-Day Moving Average 11.11 USD

DVAX Share Statistics

Avg. Volume (3 month) 1.29M USD
Avg. Daily Volume (10-Days) 1.66M USD
Shares Outstanding 128.47M
Float 121.64M
Short Ratio 14.49
% Held by Insiders 0.23%
% Held by Institutions 92.94%
Shares Short 18.7M
Short % of Float 17.78%
Short % of Shares Outstanding 14.56%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:10

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 35.99%
Operating Margin (ttm) 40.18%
Gross Margin 61.60%
EBITDA Margin 40.77%

Management Effectiveness

Return on Assets (ttm) 16.64%
Return on Equity (ttm) 55.44%

Income Statement

Revenue (ttm) 655.62M USD
Revenue Per Share (ttm) 5.15 USD
Quarterly Revenue Growth (yoy) -58.79%
Gross Profit (ttm) 448.22M USD
EBITDA 267.31M USD
Net Income Avi to Common (ttm) 235.81M USD
Diluted EPS (ttm) 1.57
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 651.96M USD
Total Cash Per Share (mrq) 5.07 USD
Total Debt (mrq) 257.82M USD
Total Debt/Equity (mrq) 45.73 USD
Current Ratio (mrq) 9.071
Book Value Per Share (mrq) 4.388

Cash Flow Statement

Operating Cash Flow (ttm) 140.78M USD
Levered Free Cash Flow (ttm) 78.86M USD

Profile of Dynavax

Country United States
State CA
City EmeryVille
Address 2100 Powell Street
ZIP 94608
Phone 510 848 5100
Website https://www.dynavax.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 351

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Q&A For Dynavax Stock

What is a current DVAX stock price?

Dynavax DVAX stock price today per share is 11.53 USD.

How to purchase Dynavax stock?

You can buy DVAX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Dynavax?

The stock symbol or ticker of Dynavax is DVAX.

Which industry does the Dynavax company belong to?

The Dynavax industry is Drug Manufacturers-Specialty & Generic.

How many shares does Dynavax have in circulation?

The max supply of Dynavax shares is 130.89M.

What is Dynavax Price to Earnings Ratio (PE Ratio)?

Dynavax PE Ratio is 164.71428000 now.

What was Dynavax earnings per share over the trailing 12 months (TTM)?

Dynavax EPS is 0.07 USD over the trailing 12 months.

Which sector does the Dynavax company belong to?

The Dynavax sector is Healthcare.

Dynavax DVAX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16920.58 USD
-0.58
6.33B USD 16873.97 USD 16989.6 USD 6.33B USD
Nasdaq US 700 Small Cap Index NQUS700SC 2092.23 USD
-1.44
2090.93 USD 2099.3 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2595.86 USD
-1.13
2595.46 USD 2605.91 USD
NASDAQ HealthCare IXHC 967.78 USD
-1.12
964.91 USD 969.79 USD
NASDAQ Capital Market Composite RCMP 111.05 USD
-1.6
110.9 USD 111.54 USD
NASDAQ Global Select Market Com NQGS 8246.62 USD
-0.57
8223.97 USD 8280.54 USD
NASDAQ Composite Total Return I XCMP 20585.06 USD
-0.58
20528.35 USD 20669.02 USD